Contraception (Birth Control) and Family Planning PubHealthInfo

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]

Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

YEAR: 1991

CATEGORY: Contraception (Birth Control) and Family Planning

TITLE

Oral contraceptives and neoplasia of the uterine corpus.

AUTHORS

Schlesselman JJ

SOURCE

CONTRACEPTION. 1991 Jun;43(6):557-79.

ABSTRACT

Effects of oral contraception on neoplasia of the uterine corpus are reviewed on the basis of epidemiologic studies

reported to date. A duration-related protective effect against endometrial cancer occurs from use of combined oral

contraceptives (OCs), those in which each active pill contains both estrogen and progestogen. The risk prior to age

60 is reduced by about 38% with 2 years of use: use of combined OCs for 4, 8, and 12 years, respectively, confers an

estimated 51%, 64%, and 70% reduction in endometrial cancer risk. The protective effect appears not to be

diminished by discontinued use, even 15 or more years after cessation. Whether protection continues throughout the

entire postmenopausal period, even in the presence of longterm hormone replacement therapy, remains to be seen.

Use of combined OCs may protect against uterine leiomyomas but evidence is not conclusive. The few findings

about the effects of OCs on risk of adenomatous hyperplasia are of uncertain validity. Only 1 study, with a few

patients, has considered OCs in relation to uterine sarcomas. (PubHealth.info Document ID: CONT3T 2003-06)

PubHealth.info NOTE: The author(s) of this article titled, "Oral contraceptives and neoplasia of the uterine corpus.",

is(are) Schlesselman JJ. The source of this article is "CONTRACEPTION. 1991 Jun;43(6):557-79.". This article was

published in 1991 in English language(s). (PubHealth.info® Document ID: CONT3T 2003-06. All rights reserved with

PubHealth.info) PIN: 12003

This article is peer-reviewed.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.